The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery

被引:6
作者
Alcock, Richard F. [1 ]
Naoum, Chris [1 ]
Aliprandi-Costa, Bernadette [1 ]
Hillis, Graham S. [1 ]
Brieger, David B. [1 ]
机构
[1] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia
关键词
Peri-operative; Anti-platelet therapy; Elective non-cardiac surgery; CORONARY-ARTERY-DISEASE; CARDIAC RISK; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; ASPIRIN; MORTALITY; VALIDATION; PREDICTORS; PREVENTION; GUIDELINES;
D O I
10.1016/j.ijcard.2011.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 34 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
[Anonymous], 2009, Carta Europeia do Coracao, P1
[3]  
[Anonymous], J AM COLL CARDIOL
[4]   Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries [J].
Artang, Ramin ;
Dieter, Robert S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08) :1039-1043
[5]   A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease [J].
Biondi-Zoccai, Giuseppe G. L. ;
Lotrionte, Marzia ;
Agostoni, Pierfrancesco ;
Abbate, Antonio ;
Fusaro, Massimiliano ;
Burzotta, Francesco ;
Testa, Luca ;
Sheiban, Imad ;
Sangiorgi, Giuseppe .
EUROPEAN HEART JOURNAL, 2006, 27 (22) :2667-2674
[6]   Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index [J].
Boersma, E ;
Kertai, MD ;
Schouten, O ;
Bax, JJ ;
Noordzij, P ;
Steyerberg, EW ;
Schinkel, AFL ;
van Santen, M ;
Simoons, ML ;
Thomson, IR ;
Klein, J ;
van Urk, H ;
Poldermans, D .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (10) :1134-1141
[7]  
BRESLOW MJ, 1993, ANESTHESIOLOGY, V79, P1202, DOI 10.1097/00000542-199312000-00010
[8]   Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence [J].
Broderick, Joseph P. ;
Bonomo, Jordan B. ;
Kissela, Brett M. ;
Khoury, Jane C. ;
Moomaw, Charles J. ;
Alwell, Kathleen ;
Woo, Daniel ;
Flaherty, Matthew L. ;
Khatri, Pooja ;
Adeoye, Opeolu ;
Ferioli, Simona ;
Kleindorfer, Dawn O. .
STROKE, 2011, 42 (09) :2509-U220
[9]   Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis [J].
Burger, W ;
Chemnitius, JM ;
Kneissl, GD ;
Rücker, G .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (05) :399-414
[10]   Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation [J].
Bursi, F ;
Babuin, L ;
Barbieri, A ;
Politi, L ;
Zennaro, M ;
Grimaldi, T ;
Rumolo, A ;
Gargiulo, M ;
Stella, A ;
Modena, MG ;
Jaffe, AS .
EUROPEAN HEART JOURNAL, 2005, 26 (22) :2448-2456